Old Web
English
Sign In
Acemap
>
authorDetail
>
Marcin Zagozda
Marcin Zagozda
PI3K/AKT/mTOR pathway
Immune system
Kinase
Immunology
Medicine
6
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Preclinical characterization of CPL302-253, a selective inhibitor of PI3Kδ, as the candidate for the inhalatory treatment and prevention of Asthma.
2020
PLOS ONE
Pawel Gunerka
Kamila Gala
Martyna Banach
Jakub Dominowski
Joanna Hucz-Kalitowska
Krzysztof Mulewski
Agnes Hajnal
Endre G. Mikus
Damian Smuga
Marcin Zagozda
Krzysztof Dubiel
Jerzy Szczepan Pieczykolan
Beata M. Zygmunt
Maciej Wieczorek
Show All
Source
Cite
Save
Citations (1)
Dérivés 7-(morpholin-4-yl)pyrazole[1,5-a]pyrimidine qui sont utiles pour le traitement de maladies immunitaires ou inflammatoires ou du cancer
2016
Barbara Dymek
Marcin Zagozda
Maciej Wieczorek
Krzysztof Dubiel
Aleksandra Stanczak
Daria Zdzalik
Pawel Gunerka
Mariola Sekular
Maciej Dziachan
Show All
Source
Cite
Save
Citations (0)
Discovery of TRAF-2 and NCK-interacting kinase (TNIK) inhibitors by ligand-based virtual screening methods
2015
MedChemComm
Anna Bujak
Filip Stefaniak
Daria Zdzalik
Paulina Grygielewicz
Barbara Dymek
Marcin Zagozda
Pawel Gunerka
Monika Lamparska-Przybysz
Krzysztof Dubiel
Maciej Wieczorek
Karolina Dzwonek
Show All
Source
Cite
Save
Citations (1)
Pharmacokinetics of selective PI3Kδ inhibitors after intratracheal instillation in mice
2015
European Respiratory Journal
Pawel Gunerka
Joanna Hucz-Kalitowska
Pawel Turowski
Marcin Zagozda
Maciej Dziachan
Mariola Sekular
Anna Bujak
Maciej Wieczorek
Show All
Source
Cite
Save
Citations (1)
1